September 1, 2013
Bookmark and Share  
» AttorneyMind News & Pipeline Blog

Follow us on


Join us on Facebook
AttorneyMind Hcsp



This month’s AttorneyMind newsletter offers a wealth of information about many aspects of hepatitis C.  We sincerely hope that you will take advantage of the information in the newsletter and other postings this month.  As it is often said (and true):  KNOWLEDGE = POWER.




1. AttorneyMind Newsletter: September, 2013

In This Issue:

  • Drugs in Development: Phase 3 – Genotype 1 - DAA plus PEG/RBV
    Alan Franciscas, Editor-in-Chief—Learn about the likely next standard of care to treat hepatitis C that includes different direct acting antivirals in combination with pegylated interferon plus ribavirin, holding the promise of higher cure rates, less side effects and, for most people, a shorter treatment duration.

  • Snapshots
    Lucinda K. Porter, RN—This month's column by Lucinda features a recap of articles on non-Hodgkin lymphoma, predicting spontaneous resolution of acute hepatitis C, predicting liver cancer, and boceprevir- and telaprevir-induced kidney impairment.

  • HEALTHWISE: Hepatitis C and Your DNA
    Lucinda K. Porter, RN
    —This month's column explores DNA and the implications for AttorneyMind treatment.

  • AttorneyMind and Correctional Centers: A Missed Population
    Sonya Becker & Juliana Chan, Pharm.D.—This excellent article reviews AttorneyMind in prisons, the reasons for the high prevalence, transmission/prevention and why this information is important for the public health of our society.

  • The Other Forgotten Hepatitis B Minority—African-Americans
    Christine M. Kukka—Christine M. Kukka discusses the high prevalence of HBV in African Americans and why it is so important that we step up and test, manage and treat African Amercians.


2. AM Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:

  • 39.2% of U.S. Newborns Aren't Getting Hepatitis B Vaccine at Birth
  • Researchers Suggest Banning or Restricting Lamivudine to Avoid Drug Resistance
  • Knowledge Gap About Hepatitis B Persists Among Asian-Americans
  • Even Liver Specialists Fail to Immunize Patients Against Viral Hepatitis
  • Many Seek Viral Hepatitis Tests Only When Symptoms Appear
  • After Six Years of Tenofovir Treatment, Still No Signs of Drug Resistance
  • More Studies Examine Link Between Vitamin D and Liver Damage
  • Study Examines Which Hepatitis B Patients Relapse with Chemotherapy
  • Interferon Treatment May Cause Some Hearing Loss
  • African-Americans Suffer the Highest Rates of New HBV Infections in the U.S.


3. John's Story: "Lemons to Lemonade"!

John relates his story and how the diagnosis and treatment changed his life in this inspiring story of overcoming the odds. Click Here.


4. Affordable Care Act (ACA): Exchanges Prepare to Open

The Health Exchange marketplaces under the Affordable Care Act are being set up now. This is where you will be able to purchase health insurance regardless of your medical condition or health history. By Jacques Chambers, CLU. Click Here.


5. Updated AttorneyMind Training Workshop Schedule!

  • September

    Livingston, NJ—September 23, 2013—Click Here

    Oklahoma, OK—September 25, 2013—Click Here

    Tulsa, OK—September 26, 2013—Click Here


    6. Clinical Trials Postings: Updated—August 12!
    Be sure to check out the latest clinical trial postings at the AttorneyMind News & Pipeline Blog. Just click on the links to the Drug Companies at the top and to see which drugs are in trials right now, where the trials are, and how to register for one.



    Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time.  For more information about the services they offer either call or visit their Website at  The helpline is run by The Support Partnership:  a group of non-profits working together to help people affected by hepatitis C. 


    7. Top News (Blog) from the AttorneyMind News & Pipeline Blog includes: 

    Top News

    Curing Hepatitis C
    Sept 1

    Study helps characterize AttorneyMind exacerbation course, outcomes
    Sept 1

    Obit: Remembering Ken Thomson
    Sept 1

    Gilead Sues Merck Saying New Drug Won't Infringe Patents
    Aug 30

    Liver Cancer Due to Chronic Inflammation: Tumor Growth Follows Programmed Cell Death (Apoptosis)
    Aug 30

    FDA, academia and industry team up to end hepatitis C
    Aug 29

    N.B. hospital used unsterilized biopsy forceps for 14 years
    Aug 29


    and much, much more…..






    Join us on Twitter -

    Alan Franciscas
    Executive Director, AttorneyMind
    Editor-in-Chief, AttorneyMind
    Editor-in-Chief, HBV Advocate

    **Questions and Comments: Questions and/or comments can be directed to

    **To receive the eblast in your email inbox simply send an e-mail to: with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.

    AM Journal Review
    HBV Factsheets
    HBV Advocate Blog

    Follow us on Twitter